Maryland Capital Management’s Amgen AMGN Stock Holding History

Maryland Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.31M	Buy	5,796 +2,500	+76%	+$606K	0.11%	88
2022 Q2	$802K	Sell	3,296 -151	-4%	-$37K	0.06%	118
2022 Q1	$834K	Sell	3,447 -381	-10%	-$87.5K	0.05%	123
2021 Q4	$861K	Sell	3,828 -181	-5%	-$38.2K	0.05%	124
2021 Q3	$852K	Buy	4,009 +34	+0.9%	+$7.83K	0.05%	119
2021 Q2	$969K	Buy	3,975 +75	+2%	+$18.4K	0.06%	115
2021 Q1	$970K	Sell	3,900 -20	-0.5%	-$4.77K	0.06%	111
2020 Q4	$901K	Sell	3,920 -216	-5%	-$49.8K	0.06%	109
2020 Q3	$1.05M	Sell	4,136 -280	-6%	-$69.4K	0.09%	97
2020 Q2	$1.04M	Buy	4,416 +677	+18%	+$154K	0.1%	92
2020 Q1	$758K	Buy	3,739 +2,643	+241%	+$577K	0.09%	100
2019 Q4	$264K	Buy	+1,096	New	+$242K	0.03%	159
2015 Q1	–	Sell	-1,841	Closed	-$293K	–	179
2014 Q4	$293K	Buy	1,841 +353	+24%	+$55K	0.05%	147
2014 Q3	$209K	Buy	+1,488	New	+$194K	0.04%	178

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maryland Capital Management's AMGN Position: Q3 2022 in Review

Maryland Capital Management increased its Amgen (AMGN) stake by 76% in Q3 2022, buying an estimated $606K and bringing the position to 5,796 shares worth $1.31M. The position accounts for 0.11% of the portfolio, ranked #88.

Maryland Capital Management first reported a position in AMGN in Q3 2014 and has held it in 14 quarters since. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Maryland Capital Management held 5,796 shares of Amgen worth $1.31M as of Q3 2022.
Maryland Capital Management bought 2,500 Amgen shares in Q3 2022, an estimated $606K.
Amgen made up 0.11% of Maryland Capital Management's portfolio in Q3 2022, its #88 holding.
Maryland Capital Management first reported a position in Amgen in Q3 2014 and has held it in 14 quarters since.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.